{"id":42379,"date":"2018-08-23T13:59:40","date_gmt":"2018-08-23T11:59:40","guid":{"rendered":"https:\/\/newserver.fyb.de\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/"},"modified":"2018-08-23T13:59:40","modified_gmt":"2018-08-23T11:59:40","slug":"c-lecta-closes-financing-round-with-capricorn-and-bmt","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/","title":{"rendered":"c\u2011LEcta closes financing round with Capricorn and bmt"},"content":{"rendered":"

Leip\u00adzig \u2014 c\u2011LEcta<\/strong>, a leading global biotech\u00adno\u00adlogy company focu\u00adsed on enzyme engi\u00adnee\u00adring and appli\u00adca\u00adti\u00adons in regu\u00adla\u00adted markets such as the food and phar\u00admaceu\u00adti\u00adcal indus\u00adtries, has closed a finan\u00adcing round with Capri\u00adcorn Venture Part\u00adners<\/strong> and the invest\u00adment company bm|t<\/strong>. The capi\u00adtal increase provi\u00addes the company with growth capi\u00adtal as well as valuable access to an inter\u00adna\u00adtio\u00adnal network.<\/p>\n

c\u2011LEcta alre\u00adady has a diver\u00adsi\u00adfied share\u00adhol\u00adder struc\u00adture. In addi\u00adtion to the foun\u00adder Dr. Marc Stru\u00adhalla<\/strong>, private inves\u00adtors from the indus\u00adtry and German insti\u00adtu\u00adtio\u00adnal inves\u00adtors, the company has now been able to expand its circle of share\u00adhol\u00adders with two new inter\u00adna\u00adtio\u00adnal inves\u00adtors. The lead inves\u00adtor Capri\u00adcorn Venture Part\u00adners is an inde\u00adpen\u00addent, inter\u00adna\u00adtio\u00adnally orien\u00adted invest\u00adment company based in Leuven (Belgium). Capri\u00adcorn invests in inno\u00adva\u00adtive, tech\u00adno\u00adlogy-driven compa\u00adnies and has a multi\u00addi\u00adsci\u00adpli\u00adnary team of expe\u00adri\u00aden\u00adced invest\u00adment mana\u00adgers. As part of the finan\u00adcing round, Capri\u00adcorn parti\u00adci\u00adpa\u00adted through two funds, Capri\u00adcorn Sustainable Chemis\u00adtry Fund NV and Quest for Growth NV.<\/p>\n

The German invest\u00adment company bm|t invests in high-growth tech\u00adno\u00adlogy compa\u00adnies led by teams of entre\u00adpre\u00adneurs. bm|t inves\u00adted via MFT Mittel\u00adstands-Fonds Th\u00fcrin\u00adgen GmbH & Co. KG. The new capi\u00adtal will be used in parti\u00adcu\u00adlar to finance the appr\u00adoval, market launch and scaling of products from the project pipe\u00adline on a commer\u00adcial scale, the further deve\u00adlo\u00adp\u00adment of the pipe\u00adline and the expan\u00adsion of inter\u00adna\u00adtio\u00adnal sales.<\/p>\n

Ludwig Goris, Invest\u00adment Mana\u00adger of Capri\u00adcorn<\/strong>, explains the invest\u00adment in c\u2011LEcta: \u201cWe see that global mega\u00adtrends and chal\u00adlenges in human nutri\u00adtion are paving the way for indus\u00adtrial biotech compa\u00adnies like c\u2011LEcta. Since its incep\u00adtion, c\u2011LEcta has built a remar\u00adkable track record in tech\u00adno\u00adlogy and product deve\u00adlo\u00adp\u00adment and has been able to vali\u00addate this with a growing custo\u00admer base of leading phar\u00admaceu\u00adti\u00adcal, chemi\u00adcal and food ingre\u00addi\u00adent compa\u00adnies. In addi\u00adtion, the highly quali\u00adfied team in Leip\u00adzig convin\u00adced us.<\/p>\n

Foun\u00adder and CEO Dr. Marc Stru\u00adhalla and his moti\u00adva\u00adted team have crea\u00adted a great company that is at an attrac\u00adtive inflec\u00adtion point where the current product pipe\u00adline provi\u00addes the foun\u00adda\u00adtion for an acce\u00adle\u00adra\u00adted growth trajec\u00adtory. We are proud to be instru\u00admen\u00adtal in this funding round and to contri\u00adbute to c\u2011LEcta\u2019s success.\u201d<\/p>\n

Kevin Reeder, CEO of bm|t (Photo)<\/strong>, adds: \u201cbm|t, which has an exten\u00adsive life scien\u00adces port\u00adfo\u00adlio, is very opti\u00admi\u00adstic about the invest\u00adment in c\u2011LEcta. We were very impres\u00adsed by the strong team, the successful deve\u00adlo\u00adp\u00adment and the compel\u00adling product pipe\u00adline. We believe c\u2011LEcta is well posi\u00adtio\u00adned to tran\u00adsi\u00adtion into a large biotech\u00adno\u00adlogy company.\u201d The two new inves\u00adtors expand the group of share\u00adhol\u00adders, which previously included the follo\u00adwing inves\u00adtors: SHS Gesell\u00adschaft f\u00fcr Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment mbH, High-Tech Gr\u00fcn\u00adder\u00adfonds Manage\u00adment GmbH, KfW Banken\u00adgruppe, Dr. Marc Stru\u00adhalla, Warning Betei\u00adli\u00adgungs GmbH, Dr. Bader <\/strong>Betei\u00adli\u00adgungs GmbH and Arthur Stein\u00admetz<\/strong>Betei\u00adli\u00adgungs GmbH.<\/p>\n

In order to streng\u00adthen the manage\u00adment as well as the execu\u00adtive board and to support the targe\u00adted growth, Thomas Pfaadt (45) has recently been appoin\u00adted CFO at c\u2011LEcta. He enri\u00adches the company with his expe\u00adri\u00adence in corpo\u00adrate finance and M&A. Previously, Thomas Pfaadt worked for a private, owner-opera\u00adted opera\u00adtor of reha\u00adbi\u00adli\u00adta\u00adtion clinics and for a family-owned inte\u00adgra\u00adted health\u00adcare group. He also gained expe\u00adri\u00adence as an invest\u00adment banker and consul\u00adtant focu\u00adsed on the health\u00adcare indus\u00adtry. Thomas Pfaadt comm\u00adents on what attracts him to c\u2011LEcta: \u201cc\u2011LEcta is a young, lean and dyna\u00admic company and at the same time a global player. We are addres\u00adsing the major chal\u00adlenges of modern human nutri\u00adtion. A growing popu\u00adla\u00adtion and an incre\u00adasing demand for healthy, natu\u00adral foods require solu\u00adti\u00adons through enzyme tech\u00adno\u00adlo\u00adgies that the chemi\u00adcal indus\u00adtry cannot provide. We are plea\u00adsed to have attrac\u00adted the two new inves\u00adtors to further deve\u00adlop our company and seize the oppor\u00adtu\u00adni\u00adties that present themselves.\u201d<\/p>\n

c\u2011LEcta is a fully inte\u00adgra\u00adted biotech\u00adno\u00adlogy company focu\u00adsed on enzyme engi\u00adnee\u00adring and biopro\u00adcess deve\u00adlo\u00adp\u00adment for regu\u00adla\u00adted markets such as the food and phar\u00admaceu\u00adti\u00adcal indus\u00adtries. c\u2011LEcta is based in Leip\u00adzig and curr\u00adently employs around 60 people. The company is broadly posi\u00adtio\u00adned and covers a large part of the value chain: the rese\u00adarch and engi\u00adnee\u00adring of enzy\u00admes through to commer\u00adcial produc\u00adtion as well as the manu\u00adfac\u00adture of other high-quality biotech\u00adno\u00adlo\u00adgi\u00adcal products are part of c\u2011LEcta\u2019s service reper\u00adtoire \u2014 either as in-house deve\u00adlo\u00adp\u00adments or in close coope\u00adra\u00adtion with indus\u00adtrial part\u00adners. c\u2011LEcta has comple\u00adted more than 30 enzyme engi\u00adnee\u00adring projects in the last 5 years with a success rate of >90%. Just a few weeks ago, c\u2011LEcta became the first company to announce a major breakth\u00adrough in a process to mass produce a plant-based sweete\u00adner with a sugar-like flavor. In addi\u00adtion, two other products with high market poten\u00adtial are at an advan\u00adced stage of deve\u00adlo\u00adp\u00adment and the project pipe\u00adline includes seve\u00adral promi\u00adsing candi\u00adda\u00adtes for the multi-billion euro food ingre\u00addi\u00adent market. The finan\u00adcing is inten\u00added to enable c\u2011LEcta to grow stron\u00adgly and to<\/p>\n

About c\u2011LEcta<\/strong>
\nc\u2011LEcta is a fully inte\u00adgra\u00adted biotech\u00adno\u00adlogy company focu\u00adsed on enzyme engi\u00adnee\u00adring and biopro\u00adcess deve\u00adlo\u00adp\u00adment for regu\u00adla\u00adted markets such as the food and phar\u00admaceu\u00adti\u00adcal indus\u00adtries. c\u2011LEcta is based in Leip\u00adzig and curr\u00adently employs around 60 people. The company is broadly posi\u00adtio\u00adned and covers a large part of the value chain: the rese\u00adarch and engi\u00adnee\u00adring of enzy\u00admes through to commer\u00adcial produc\u00adtion as well as the manu\u00adfac\u00adture of other high-quality biotech\u00adno\u00adlo\u00adgi\u00adcal products are part of c\u2011LEcta\u2019s service reper\u00adtoire \u2014 either as in-house deve\u00adlo\u00adp\u00adments or in close coope\u00adra\u00adtion with indus\u00adtrial part\u00adners. c\u2011LEcta has comple\u00adted more than 30 enzyme engi\u00adnee\u00adring projects in the last 5 years with a success rate of >90%. Just a few weeks ago, c\u2011LEcta became the first company to announce a major breakth\u00adrough in a process to mass produce a plant-based sweete\u00adner with a sugar-like flavor. In addi\u00adtion, two other products with high market poten\u00adtial are at an advan\u00adced stage of deve\u00adlo\u00adp\u00adment and the project pipe\u00adline includes seve\u00adral promi\u00adsing candi\u00adda\u00adtes for the multi-billion euro food ingre\u00addi\u00adent market. The funding is expec\u00adted to enable c\u2011LEcta to grow stron\u00adgly and lift food ingre\u00addi\u00adents out of the project pipe\u00adline and into commer\u00adcial produc\u00adtion scale.<\/p>\n

CEO Dr. Marc Stru\u00adhalla explains the core tech\u00adno\u00adlogy of c\u2011LEcta and the capi\u00adtal increase: \u201cThe perfor\u00admance requi\u00adre\u00adments for enzy\u00admes used in indus\u00adtrial proces\u00adses are in most cases very speci\u00adfic and diffe\u00adrent from natu\u00adrally occur\u00adring vari\u00adants. Enzy\u00admes ther\u00ade\u00adfore need to be adapted to indus\u00adtrial condi\u00adti\u00adons by enzyme engi\u00adnee\u00adring and c\u2011LEcta has one of the most effi\u00adci\u00adent tech\u00adno\u00adlogy plat\u00adforms in this field. For enzyme opti\u00admiza\u00adtion as well as for the deve\u00adlo\u00adp\u00adment of arti\u00adfi\u00adcial enzyme acti\u00advi\u00adties, we use proprie\u00adtary methods inspi\u00adred by nature. The indus\u00adtrial appli\u00adca\u00adtion of these tech\u00adno\u00adlo\u00adgies holds great market poten\u00adtial. The strong finan\u00adcial base and valuable inter\u00adna\u00adtio\u00adnal network we have gained through this finan\u00adcing round now gives us the oppor\u00adtu\u00adnity to exploit the full poten\u00adtial of our tech\u00adno\u00adlo\u00adgies and our people. With Capri\u00adcorn Venture Part\u00adners and bm|t, we were able to bring on board two active inves\u00adtors who can contri\u00adbute signi\u00adfi\u00adcantly to our inter\u00adna\u00adtio\u00adnal growth ambi\u00adti\u00adons. I am all the more plea\u00adsed that Thomas Pfaadt will support us as our new CFO. Our goal is for c\u2011LEcta\u2019s tech\u00adno\u00adlo\u00adgies to be used in many things in ever\u00ady\u00adday life in the future.\u201d<\/p>\n

About Capri\u00adcorn Venture Partners<\/strong>
\nCapri\u00adcorn Venture Part\u00adners is an inde\u00adpen\u00addent Euro\u00adpean mana\u00adger of venture capi\u00adtal and equity funds inves\u00adt\u00ading in inno\u00adva\u00adtive Euro\u00adpean compa\u00adnies with a compe\u00adti\u00adtive tech\u00adno\u00adlo\u00adgi\u00adcal advan\u00adtage. It is based in Leuven (Belgium) and is licen\u00adsed by the FSMA (Finan\u00adcial Services and Markets Autho\u00adrity in Belgium).<\/p>\n

About bm|t<\/strong>
\nErfurt-based bm|t betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment th\u00fcrin\u00adgen gmbh (bm|t) is the largest growth inves\u00adtor in Thurin\u00adgia. bm|t invests in inno\u00adva\u00adtive compa\u00adnies with high growth poten\u00adtial in all indus\u00adtries and phases of the company life cycle.<\/p>\n

About c\u2011LEcta<\/strong>
\nc\u2011LEcta is a fully inte\u00adgra\u00adted, world-leading biotech\u00adno\u00adlogy company focu\u00adsed on enzyme engi\u00adnee\u00adring and biopro\u00adcess deve\u00adlo\u00adp\u00adment for regu\u00adla\u00adted markets such as the food and phar\u00admaceu\u00adti\u00adcal indus\u00adtries. The Leip\u00adzig-based company has estab\u00adlished itself as a leading provi\u00adder in the realiza\u00adtion of high-quality biotech\u00adno\u00adlo\u00adgi\u00adcal products, whether in in-house deve\u00adlo\u00adp\u00adments or in close coope\u00adra\u00adtion with indus\u00adtry. c\u2011LEcta curr\u00adently employs around 60 people.<\/p>\n

c\u2011LEcta deli\u00advers cost-effi\u00adci\u00adent and sustainable produc\u00adtion proces\u00adses that open up new markets and enable better pene\u00adtra\u00adtion of exis\u00adting markets. The company excels in the rapid and effi\u00adci\u00adent deve\u00adlo\u00adp\u00adment of best-in-class biotech solu\u00adti\u00adons and the successful launch and commer\u00adcia\u00adliza\u00adtion of the resul\u00adting products. This allows c\u2011LEcta to unleash the unique poten\u00adtial of its core tech\u00adno\u00adlo\u00adgies. c\u2011LEcta alre\u00adady has more than 10 successfully marke\u00adted, high-quality, indus\u00adtrial biotech products.<\/p>\n

About High-Tech Gr\u00fcnderfonds
\nThe seed inves\u00adtor High-Tech Gr\u00fcnderfonds(HTGF) finan\u00adces tech\u00adno\u00adlogy start\u00adups with growth poten\u00adtial. With a total volume of 892.5 million euros distri\u00adbu\u00adted over three funds (272 million euros Fund I, 304 million euros Fund II, 316.5 million euros Fund III) and an inter\u00adna\u00adtio\u00adnal part\u00adner network, HTGF has alre\u00adady supported 506 start-ups since 2005. His team of expe\u00adri\u00aden\u00adced invest\u00adment mana\u00adgers and startup experts supports the young compa\u00adnies with know-how, entre\u00adpre\u00adneu\u00adrial spirit and passion. The focus is on high-tech start-ups in the soft\u00adware, media and Inter\u00adnet sectors, as well as hard\u00adware, auto\u00adma\u00adtion, health\u00adcare, chemi\u00adcals and life scien\u00adces. More than \u20ac1.8 billion in capi\u00adtal has been inves\u00adted in the HTGF port\u00adfo\u00adlio by exter\u00adnal inves\u00adtors in over 1,300 follow-on finan\u00adcing rounds to date. The fund has also successfully sold shares in more than 90 companies.<\/p>\n","protected":false},"excerpt":{"rendered":"

Leip\u00adzig \u2014 c\u2011LEcta, a leading global biotech\u00adno\u00adlogy company focu\u00adsed on enzyme engi\u00adnee\u00adring and appli\u00adca\u00adti\u00adons in regu\u00adla\u00adted markets such as the food and phar\u00admaceu\u00adti\u00adcal indus\u00adtries, has closed a finan\u00adcing round with Capri\u00adcorn Venture Part\u00adners and the invest\u00adment company bm|t. The capi\u00adtal increase provi\u00addes the company with growth capi\u00adtal as well as valuable access to an international [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":42391,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366],"tags":[],"class_list":["post-42379","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","news-category-venture-capital-news"],"yoast_head":"\nc-LEcta closes financing round with Capricorn and bmt - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"c-LEcta closes financing round with Capricorn and bmt - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Leip\u00adzig \u2014 c\u2011LEcta, a leading global biotech\u00adno\u00adlogy company focu\u00adsed on enzyme engi\u00adnee\u00adring and appli\u00adca\u00adti\u00adons in regu\u00adla\u00adted markets such as the food and phar\u00admaceu\u00adti\u00adcal indus\u00adtries, has closed a finan\u00adcing round with Capri\u00adcorn Venture Part\u00adners and the invest\u00adment company bm|t. The capi\u00adtal increase provi\u00addes the company with growth capi\u00adtal as well as valuable access to an inter\u00adna\u00adtio\u00adnal […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2018-08-23T11:59:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/08\/a-kevin-e1535025545960.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"248\" \/>\n\t<meta property=\"og:image:height\" content=\"223\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"c\u2011LEcta closes financing round with Capricorn and bmt\",\"datePublished\":\"2018-08-23T11:59:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/\"},\"wordCount\":1487,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/08\/a-kevin-e1535025545960.jpg\",\"articleSection\":[\"General\",\"Featured\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/\",\"url\":\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/\",\"name\":\"c-LEcta closes financing round with Capricorn and bmt - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/08\/a-kevin-e1535025545960.jpg\",\"datePublished\":\"2018-08-23T11:59:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/08\/a-kevin-e1535025545960.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/08\/a-kevin-e1535025545960.jpg\",\"width\":248,\"height\":223},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"c\u2011LEcta closes financing round with Capricorn and bmt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"c-LEcta closes financing round with Capricorn and bmt - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/","og_locale":"en_US","og_type":"article","og_title":"c-LEcta closes financing round with Capricorn and bmt - FYB Financial Yearbook","og_description":"Leip\u00adzig \u2014 c\u2011LEcta, a leading global biotech\u00adno\u00adlogy company focu\u00adsed on enzyme engi\u00adnee\u00adring and appli\u00adca\u00adti\u00adons in regu\u00adla\u00adted markets such as the food and phar\u00admaceu\u00adti\u00adcal indus\u00adtries, has closed a finan\u00adcing round with Capri\u00adcorn Venture Part\u00adners and the invest\u00adment company bm|t. The capi\u00adtal increase provi\u00addes the company with growth capi\u00adtal as well as valuable access to an inter\u00adna\u00adtio\u00adnal […]","og_url":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2018-08-23T11:59:40+00:00","og_image":[{"width":248,"height":223,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/08\/a-kevin-e1535025545960.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"c\u2011LEcta closes financing round with Capricorn and bmt","datePublished":"2018-08-23T11:59:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/"},"wordCount":1487,"commentCount":0,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/08\/a-kevin-e1535025545960.jpg","articleSection":["General","Featured","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/","url":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/","name":"c-LEcta closes financing round with Capricorn and bmt - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/08\/a-kevin-e1535025545960.jpg","datePublished":"2018-08-23T11:59:40+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/08\/a-kevin-e1535025545960.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/08\/a-kevin-e1535025545960.jpg","width":248,"height":223},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/c-lecta-closes-financing-round-with-capricorn-and-bmt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"c\u2011LEcta closes financing round with Capricorn and bmt"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=42379"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42379\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/42391"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=42379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=42379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=42379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}